Editorial Page 1 of 5 Oncogenic potential of BMI1: race-based evidence in prostate cancer Eswar Shankar1,2, Shiv Verma1, Sanjay Gupta1,2,3,4,5 1Department of Urology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA; 2The Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA; 3Department of Urology, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH 44106, USA; 4Department of Nutrition, Case Western Reserve University, Cleveland, OH 44106, USA; 5Division of General Medical Sciences, Case Comprehensive Cancer Center, Cleveland, OH 44106, USA Correspondence to: Sanjay Gupta, PhD. Department of Urology, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, USA. Email:
[email protected]. Provenance: This is an invited Editorial commissioned by Section Editor Xiao Li (Department of Urologic Surgery, The Affiliated Cancer Hospital of Jiangsu Province of Nanjing Medical University, Nanjing, China). Comment on: Ganaie AA, Beigh FH, Astone M, et al. BMI1 Drives Metastasis of Prostate Cancer in Caucasian and African-American Men and Is A Potential Therapeutic Target: Hypothesis Tested in Race-specific Models. Clin Cancer Res 2018. [Epub ahead of print]. Received: 12 October 2018; Accepted: 02 November 2018; Published: 09 November 2018. doi: 10.21037/amj.2018.11.01 View this article at: http://dx.doi.org/10.21037/amj.2018.11.01 A recent publication by Ganaie et al. (1) in Clinical Cancer sequence between various species (4). The human BMI1 Research (doi: 10.1158/1078-0432.CCR-18-1394, 2018) gene is localized on chromosome 10 (10p11.23) (Figure 1A). demonstrate BMI1 as a potential driver of metastasis in The BMI1 protein comprises of 326 amino acids having prostate cancer.